Solstice Advanced Materials Reports Third Quarter 2026 Results

Solstice Advanced Materials Inc. (SOLS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Solstice Advanced Materials Reports Third Quarter 2026 Results • Net Sales of $1,046 million exceeded guidance, up 8% YoY reflecting robust growth in Electronic Materials, Refrigerants, and Healthcare Packaging • Net Income attributable to Solstice Advanced Materials

Event · Earnings
Also in this documentGuidance · raise · $4.2B–$4.22BBuyback · $500MDividend · regular · $0.075

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 4, 2026, 11:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SOLS
Bullish
high confidence
Mentioned
$SOLS
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SOLSBullishHigh
01

Why it matters

The earnings beat and raised guidance provide a clear catalyst for price movement, while the $500 m share‑repurchase program adds further support.

02

Market read

First‑time disclosure of earnings beat and raised guidance makes this a high‑impact earnings story for SOLS.

03

What to watch

Higher interest expense and modest cash conversion could temper enthusiasm.

Relevance 8/10Novelty 8/10Timing: after‑hours release
AlphAI · Earnings readSOLS · third quarter of 2026 · ended September 30, 2026

Third-quarter Net Sales rose 8% to $1,046 million, adjusted diluted EPS was $0.80, and Solstice raised its full-year 2026 outlook.

✓Strong quarter

Net Sales, adjusted EBITDA, and both operating segments grew year over year; ESM delivered record quarterly sales and material margin expansion; operating cash flow was $693 million for the nine months; and the company raised full-year Net Sales, Adjusted EBITDA, and Adjusted diluted EPS guidance.

Revenue
$1.05B
8% y/y
Refrigerants & Applied Solutions segment
$726M
6% y/y
EPS · non-GAAP
$0.80
N/A y/y
Full-Year 2026 and 4Q 2026 outlook
Full-Year 2026: $4,195 - $4,220 million; 4Q 2026: $1,010 - $1,035 million

Actuals vs. the company’s prior outlook

from its previous release
MetricGuidedReportedVerdict
Net sales, Q3 2026$990 - $1,030$1,046 millionabove

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net Sales, three months ended September 30, 2026GAAP$1.05B–8%
Product sales, three months ended September 30, 2026GAAP$980M––
Service sales, three months ended September 30, 2026GAAP$66M––
Total cost of products and services sold, three months ended September 30, 2026GAAP$701M––
Research and development expenses, three months ended September 30, 2026GAAP$30M––
Selling, general and administrative expenses, three months ended September 30, 2026GAAP$120M––
Transaction-related costs, three months ended September 30, 2026GAAP$31M––
Interest and other financial charges, three months ended September 30, 2026GAAP$60M––
Income before taxes, three months ended September 30, 2026GAAP$112M––
Income tax expense, three months ended September 30, 2026GAAP$24M––
Effective tax rate, three months ended September 30, 2026GAAP22%––
Net income, three months ended September 30, 2026GAAP$88M––
Net income attributable to Solstice Advanced Materials, three months ended September 30, 2026GAAP$80M–NM
Diluted earnings per share, three months ended September 30, 2026GAAP$0.50–NM
Adjusted net income attributable to Solstice, three months ended September 30, 2026non-GAAP$127M––
Adjusted diluted EPS, three months ended September 30, 2026non-GAAP$0.80–N/A
Adjusted EBITDA, three months ended September 30, 2026non-GAAP$265M––
Adjusted EBITDA Margin, three months ended September 30, 2026non-GAAP25.3%––
Adjusted Standalone EBITDA, three months ended September 30, 2026non-GAAP$265M–13%
Adjusted Standalone EBITDA Margin, three months ended September 30, 2026non-GAAP25.3%–109 bps
Organic sales percentage, three months ended September 30, 2026non-GAAP8.3 %–8.3 %
Net Sales, nine months ended September 30, 2026GAAP$3.19B––
Product sales, nine months ended September 30, 2026GAAP$2.96B––
Service sales, nine months ended September 30, 2026GAAP$229M––
Net income attributable to Solstice Advanced Materials, nine months ended September 30, 2026GAAP$283M––
Diluted earnings per share, nine months ended September 30, 2026GAAP$1.78––
Adjusted net income attributable to Solstice, nine months ended September 30, 2026non-GAAP$367M––
Adjusted diluted EPS, nine months ended September 30, 2026non-GAAP$2.31––
Adjusted EBITDA, nine months ended September 30, 2026non-GAAP$804M––
Adjusted EBITDA Margin, nine months ended September 30, 2026non-GAAP25.2 %––
Adjusted Standalone EBITDA, nine months ended September 30, 2026non-GAAP$804M––
Adjusted Standalone EBITDA Margin, nine months ended September 30, 2026non-GAAP25.2 %––
Organic sales percentage, nine months ended September 30, 2026non-GAAP9.0 %–9.0 %
LTM Adjusted Standalone EBITDA ended September 30, 2026non-GAAP$993M––

Segments

SegmentRevenueq/qy/y
Refrigerants & Applied Solutions segmentRefrigerants Net Sales increased 8%, reflecting strong demand across automotive and data center applications; Healthcare Packaging improved 24% following destocking in the second half of 2025.$726M–6%
RefrigerantsStrong demand across automotive and data center applications.$433M–8%
Building Solutions & IntermediatesConstruction-related end markets remained soft.$167M–(5)%
NuclearDemand for the Company’s conversion services continues to be robust, with backlog for Nuclear now at $2.6 billion.$66M–4%
Healthcare PackagingHigher volume and pricing following destocking in the second half of 2025.$61M–24%
Electronic & Specialty Materials segmentRecord quarterly Net Sales, led by a 31% increase in Electronic Materials.$320M–13%
Electronic MaterialsIncreased demand for sputtering targets and thermal solutions in memory and AI-related applications.$135M–31%
Research & Performance ChemicalsHigher demand for specialty additives.$131M–4%
Safety & Defense SolutionsImproved volumes.$54M–3%

Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.

Full-Year 2026 and 4Q 2026 outlook

  • RevenueFull-Year 2026: $4,195 - $4,220 million; 4Q 2026: $1,010 - $1,035 million
  • NoteAdjusted EBITDA (non-GAAP): Full-Year 2026 $1,050 - $1,060 million; 4Q 2026 $246 - $256 million
  • NoteAdjusted Diluted EPS (non-GAAP): Full-Year 2026 $2.90 - $2.95; 4Q 2026 $0.57 - $0.62
  • NoteCapital Expenditures: $420 - $440 million; Unchanged

Capital returns

  • Returned $112 million to shareowners in the third quarter including $100 million of share repurchases.
  • During the three months ended September 30, 2026, the Company completed $100 million of the program, repurchasing 1.7 million shares of its common stock.
  • Share repurchase program authorizes the repurchase of up to $500 million of common stock; the Company intends to substantially complete the authorization by the end of the first quarter of 2027.
  • Quarterly dividend of $0.075 per share of common stock outstanding, payable on December 10, 2026, to shareowners of record as of November 25, 2026.
  • Dividends for the nine months ended September 30, 2026 were $(36) million.

What drove it

  • Organic Net Sales increased by 8% in the third quarter of 2026, driven by both volume and price.
  • Consolidated adjusted EBITDA margin increased 109 basis points to 25.3%, reflecting Net Sales growth and operational leverage.
  • RAS Segment Adjusted EBITDA was $251 million, compared with $243 million, while RAS Segment Adjusted EBITDA Margin was 34.5%, compared with 35.4%.
  • ESM Segment Adjusted EBITDA was $68 million, compared with $47 million, and ESM Segment Adjusted EBITDA Margin was 21.2%, compared with 16.7%.
  • Solstice completed ~$30 million of previously communicated product loan returns in the quarter.
  • Net income attributable to Solstice increased primarily due to higher Net Sales and lower income taxes, partially offset by higher interest expense.

Concerns

  • Building Solutions & Intermediates Net Sales decreased 5% as construction-related end markets remained soft.
  • RAS Segment Adjusted EBITDA Margin was down 82 basis points year over year due in part to higher R&D investment.
  • Interest and other financial charges were $60 million in the third quarter of 2026, compared with $2 million in the third quarter of 2025.
  • Interest and other financial charges included $34 million of amortization and write-off of fees related to a bridge loan facility and backstop revolving credit facility associated with the terminated merger of Element Solutions Inc.
  • Capital expenditures were $325 million for the nine months ended September 30, 2026, a 31% increase due to planned increases in capital spending intended to drive long-term growth.

What to watch

  • Fourth-quarter 2026 Net Sales guidance of $1,010 - $1,035 million.
  • Fourth-quarter 2026 Adjusted EBITDA guidance of $246 - $256 million and Adjusted Diluted EPS guidance of $0.57 - $0.62.
  • Execution toward full-year 2026 Net Sales guidance of $4,195 - $4,220 million and Adjusted EBITDA guidance of $1,050 - $1,060 million.
  • Nuclear conversion-services demand and the $2.6 billion Nuclear backlog.
  • The intended substantial completion of the $500 million share repurchase authorization by the end of the first quarter of 2027.
  • RAS margin performance following the 82 basis point year-over-year decline and 160 basis point sequential improvement.

Balance sheet and cash flow

  • Operating Cash Flow for the nine months ended September 30, 2026 was $693 million, compared with $289 million for the prior-year period.
  • Capital Expenditures for the nine months ended September 30, 2026 were $325 million, compared with $248 million for the prior-year period; the company described this as a 31% increase.
  • Free Cash Flow for the nine months ended September 30, 2026 was $368 million.
  • Cash and cash equivalents were $714 million as of September 30, 2026, compared with $534 million as of December 31, 2025.
  • Total Debt was $1,968 million, Net Debt was $1,254 million, Total Leverage Ratio was 2.0 x, and Net Leverage Ratio was 1.3 x as of September 30, 2026.
  • Total liquidity was approximately $1.7 billion, including Cash and Cash Equivalents and $1.0 billion of availability through the revolving credit facility.
  • Total assets were $6,074 million and total liabilities were $4,500 million as of September 30, 2026.

Analysis

Solstice reported third-quarter Net Sales of $1,046 million, up 8% from $969 million. Organic sales percentage was 8.3 %, and the company said growth was driven by both volume and price. Net income attributable to Solstice Advanced Materials was $80 million, compared with a $35 million loss in the prior-year quarter, while GAAP diluted EPS was $0.50 and adjusted diluted EPS was $0.80.

Profitability improved at the adjusted EBITDA level. Adjusted Standalone EBITDA was $265 million versus $235 million, and Adjusted Standalone EBITDA Margin rose 109 basis points to 25.3%. The release attributed the margin expansion to Net Sales growth and operational leverage. The GAAP income comparison also reflects a sharp decrease in income tax expense to $24 million from $182 million, although interest and other financial charges increased to $60 million from $2 million.

Growth was concentrated in Electronic & Specialty Materials. ESM generated record quarterly Net Sales of $320 million, up 13%, with Electronic Materials up 31% on demand for sputtering targets and thermal solutions in memory and AI-related applications. ESM Segment Adjusted EBITDA increased to $68 million from $47 million, and its margin increased to 21.2% from 16.7%. RAS revenue grew 6% to $726 million, supported by Refrigerants and Healthcare Packaging, but Building Solutions & Intermediates declined 5% amid soft construction-related end markets. RAS margin was 34.5%, down from 35.4%, in part due to higher R&D investment.

Cash generation was substantial through the first nine months. Operating cash flow was $693 million and free cash flow was $368 million after $325 million of capital expenditures. Cash and cash equivalents were $714 million, Net Debt was $1,254 million, and Net Leverage Ratio was 1.3 x as of September 30, 2026. The company deployed $100 million to repurchase 1.7 million shares during the quarter, declared a $0.075 per-share quarterly dividend, and intends to substantially complete the $500 million authorization by the end of the first quarter of 2027.

Management raised full-year 2026 guidance for Net Sales to $4,195 - $4,220 million, Adjusted EBITDA to $1,050 - $1,060 million, and Adjusted Diluted EPS to $2.90 - $2.95. Fourth-quarter guidance calls for Net Sales of $1,010 - $1,035 million, Adjusted EBITDA of $246 - $256 million, and Adjusted Diluted EPS of $0.57 - $0.62. Capital expenditures guidance remains $420 - $440 million. Key operating variables are the persistence of electronic-materials demand, realization of the $2.6 billion Nuclear backlog, RAS margin recovery, and the pressure from higher interest charges.

Management, verbatim

Solstice delivered strong third-quarter results, demonstrating the value of our differentiated portfolio and consistent execution.

David Sewell, President and Chief Executive Officer

Our strong business performance year-to-date gives us confidence to raise our full-year outlook for the second consecutive quarter.

David Sewell, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • GAAP gross profit and GAAP gross margin were not reported.
  • GAAP operating income was not reported.
  • Prior-quarter values for the reported metrics were not reported, except that RAS Segment Adjusted EBITDA Margin was stated to have improved 160 basis points sequentially.
  • Forward guidance for gross margin, operating expenses, and tax rate was not reported.
  • A reconciliation of forward-looking Adjusted EBITDA and Adjusted diluted EPS to GAAP net income was not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Solstice Advanced Materials (Nasdaq: SOLS) filed a Form 8‑K reporting Q3 2026 results, including net sales of $1.046 bn, net income of $80 m, and an updated full‑year outlook.

Company-level read

Ticker impact

$SOLSBullishHigh confidence
Context

Solstice Advanced Materials reported Q3 2026 results beating prior loss and raised full-year 2026 guidance on net sales, EBITDA and EPS.

Expected impact

likely upward pressure as investors price in higher guidance and ongoing share repurchases

Evidence & confidence

The 8‑K filing is the first public disclosure of the earnings beat and the raised full‑year outlook, providing fresh material for traders.

Market effects

Strong results may lift the specialty materials and electronic materials sectors.

Positive for U.S. industrial and tech‑related stocks.

Reinforces demand trends in AI data centers and thermal management worldwide.

Counterpoint

If the raised guidance is already priced in, the stock could face a short‑term pull‑back.

Key entities

  • Solstice Advanced Materials

    Specialty materials producer that issued the earnings release.

Every SOLS earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$SOLSMed

Solstice Advanced Materials Inc (SOLS) (Q3 2026) Earnings Call Highlights: Record

Solstice Advanced Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, exceeding guidance. Adjusted EBITDA rose 13% to $265M. Electronic materials sales surged 31%, while nuclear backlog grew to $2.6B. The company raised full-year guidance and plans to complete $500M in share repurchases by Q1 2027. Challenges include declines in building solutions and nuclear sales, capacity constraints, and terminated M&A plans.

$SOLSHighAI 8/10

What Solstice Advanced Mat (SOLS) Said on Its Q3 Earnings Call

Solstice Advanced Materials (SOLS) reported Q3 sales of $726M, up 6% YoY, with adjusted EBITDA rising 3% to $251M. Refrigerant sales increased 8%, offsetting residential market weakness. Nuclear backlog reached $2.6B. The company raised its full-year sales and EPS guidance, plans to complete share buybacks by Q1 2027, and is evaluating expansion projects.

$SOLSMedAI 8/10

Solstice Adv. Materials (SOLS) Q3 2026 Earnings Call Transcript

Solstice Adv. Materials (SOLS) reported Q3 2026 net sales of $1.05B, up 8% YoY, and raised full-year guidance. The company completed $100M in share repurchases and plans to finish the remaining $400M by Q1 2027. It highlighted growth in data center and nuclear conversion businesses, with a $2.6B nuclear backlog. Adjusted EBITDA rose 13% to $265M, and adjusted EPS was $0.80.